TRHDE-AS1

 

Full name: TRHDE antisense RNA 1 Alias Symbol: 
Type: non-coding RNA Cytoband: 12q21.1
Entrez ID: 283392 HGNC ID: HGNC:27471 Ensembl Gene: ENSG00000236333 OMIM ID: 
Drug and gene relationship at DGIdb

 

Expression of TRHDE-AS1:

 

Dataset Gene EntrezID Probe Log2FC Adj.pValue Expression
GSE17351 TRHDE-AS1 283392 1560698_a_at 0.8246 0.3463
GSE26886 TRHDE-AS1 283392 1560697_at -0.2629 0.0034
GSE45670 TRHDE-AS1 283392 1560698_a_at -0.1636 0.1961
GSE53622 TRHDE-AS1 283392 19510 0.0785 0.2297
GSE53624 TRHDE-AS1 283392 99784 0.3441 0.0012
GSE63941 TRHDE-AS1 283392 1560697_at -1.3930 0.0008
GSE77861 TRHDE-AS1 283392 1560697_at -0.1067 0.2745
SRP133303 TRHDE-AS1 283392 RNAseq 0.2122 0.6145

Upregulated datasets: 0; Downregulated datasets: 1.  


 

Survival by TRHDE-AS1 expression:

 

GSE53622GSE53624

 

Note: Click image to view full size file.  


Copy number change of TRHDE-AS1:

 

Dataset Gene EntrezID Gain Loss Normal Detail
GSE15526 TRHDE-AS1 283392 4 3 23
GSE20123 TRHDE-AS1 283392 4 3 23
GSE43470 TRHDE-AS1 283392 3 0 40
GSE46452 TRHDE-AS1 283392 8 1 50
GSE47630 TRHDE-AS1 283392 10 1 29
GSE54993 TRHDE-AS1 283392 0 5 65
GSE54994 TRHDE-AS1 283392 5 2 46
GSE60625 TRHDE-AS1 283392 0 0 11
GSE74703 TRHDE-AS1 283392 3 0 33
GSE74704 TRHDE-AS1 283392 3 2 15

Total number of gains: 40; Total number of losses: 17; Total Number of normals: 335.  


 

Somatic mutations of TRHDE-AS1:

 

Generating mutation plots.

 

Highly correlated genes for TRHDE-AS1:

 

Showing all 17 correlated genes with mean PCC>0.5.

Gene1 Gene2 Mean PCC Num. Datasets Num. PCC<0 Num. PCC>0.5
TRHDE-AS1LINC011110.703479303
TRHDE-AS1LINC010940.665792303
TRHDE-AS1TRHDE0.639946403
TRHDE-AS1RAB240.63578303
TRHDE-AS1NEK10.630329303
TRHDE-AS1LIMD10.609422303
TRHDE-AS1STT3A0.607271303
TRHDE-AS1TEX260.601686303
TRHDE-AS1HECW20.590168303
TRHDE-AS1TTN0.585927303
TRHDE-AS1FAM126B0.580909303
TRHDE-AS1PMVK0.574255303
TRHDE-AS1SFMBT20.570212303
TRHDE-AS1GOLGA6L60.56546403
TRHDE-AS1ACE0.56385403
TRHDE-AS1ZNF5830.561454403
TRHDE-AS1PLIN20.552541303

For details and further investigation, click here